Clinical trial
The Systemic And Local Immune Response To Intranasal Influenza Vaccination
NCT01866540 is registered in ClinicalTrials.gov with University of Bergen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Systemic And Local Immune Response To Intranasal Influenza Vaccination
- Lead sponsor
- University of Bergen
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 1, 2012
- Completion date
- December 31, 2030
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tonsillitis, hypertrophy